These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 22294456)

  • 61. From plasmacytoid to dendritic cell: morphological and functional switches during plasmacytoid pre-dendritic cell differentiation.
    Soumelis V; Liu YJ
    Eur J Immunol; 2006 Sep; 36(9):2286-92. PubMed ID: 16892183
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Human natural killer cells promote cross-presentation of tumor cell-derived antigens by dendritic cells.
    Deauvieau F; Ollion V; Doffin AC; Achard C; Fonteneau JF; Verronese E; Durand I; Ghittoni R; Marvel J; Dezutter-Dambuyant C; Walzer T; Vie H; Perrot I; Goutagny N; Caux C; Valladeau-Guilemond J
    Int J Cancer; 2015 Mar; 136(5):1085-94. PubMed ID: 25046660
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dendritic cells as a tool to combat infectious diseases.
    Moll H
    Immunol Lett; 2003 Jan; 85(2):153-7. PubMed ID: 12527222
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Dendritic/tumor fusion cell-based vaccination against cancer.
    Koido S; Hara E; Homma S; Fujise K; Gong J; Tajiri H
    Arch Immunol Ther Exp (Warsz); 2007; 55(5):281-7. PubMed ID: 18219758
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Artificial antigen-presenting cells are superior to dendritic cells at inducing antigen-specific cytotoxic T lymphocytes.
    Shao J; Xu Q; Su S; Wei J; Meng F; Chen F; Zhao Y; Du J; Zou Z; Qian X; Liu B
    Cell Immunol; 2018 Dec; 334():78-86. PubMed ID: 30392890
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Dendritic cells in cancer immunotherapy.
    Gunzer M; Grabbe S
    Crit Rev Immunol; 2001; 21(1-3):133-45. PubMed ID: 11642600
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Enhancement of antigen presenting ability in the leukemic plasmacytoid dendritic cell line (PMDC05) by lentiviral vector-mediated transduction of CD80 gene.
    Yamahira A; Narita M; Ishii K; Jayathilake RM; Iwabuchi M; Satoh N; Uchiyama T; Taniguchi T; Hashimoto S; Kasahara N; Faure E; Bogan B; Takizawa J; Sone H; Takahashi M
    Leuk Res; 2012 Dec; 36(12):1541-6. PubMed ID: 23040531
    [TBL] [Abstract][Full Text] [Related]  

  • 68. CLEC12A-Mediated Antigen Uptake and Cross-Presentation by Human Dendritic Cell Subsets Efficiently Boost Tumor-Reactive T Cell Responses.
    Hutten TJ; Thordardottir S; Fredrix H; Janssen L; Woestenenk R; Tel J; Joosten B; Cambi A; Heemskerk MH; Franssen GM; Boerman OC; Bakker LB; Jansen JH; Schaap N; Dolstra H; Hobo W
    J Immunol; 2016 Oct; 197(7):2715-25. PubMed ID: 27566820
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Activation of human plasmacytoid dendritic cells by TLR9 impairs Fc gammaRII-mediated uptake of immune complexes and presentation by MHC class II.
    Benitez-Ribas D; Tacken P; Punt CJ; de Vries IJ; Figdor CG
    J Immunol; 2008 Oct; 181(8):5219-24. PubMed ID: 18832675
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dendritic cells: interfaces with immunobiology and medicine. A report from the Keystone Symposia Meeting held in Keystone, 3-8 March 2003.
    Mohty M; Gaugler B
    Leukemia; 2003 Sep; 17(9):1753-8. PubMed ID: 12970774
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The labyrinth unfolds: architectural rearrangements of the endolysosomal system in antigen-presenting cells.
    Perrin P; Jongsma ML; Neefjes J; Berlin I
    Curr Opin Immunol; 2019 Jun; 58():1-8. PubMed ID: 30738283
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Ex vivo enhancement of antigen-presenting function of dendritic cells and its application for DC-based immunotherapy.
    Nieda M; Tomiyama M; Egawa K
    Hum Cell; 2003 Dec; 16(4):199-204. PubMed ID: 15147040
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dendritic cells and HCMV cross-presentation.
    Arrode G; Davrinche C
    Curr Top Microbiol Immunol; 2003; 276():277-94. PubMed ID: 12797453
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Naturally produced type I IFNs enhance human myeloid dendritic cell maturation and IL-12p70 production and mediate elevated effector functions in innate and adaptive immune cells.
    Sköld AE; Mathan TSM; van Beek JJP; Flórez-Grau G; van den Beukel MD; Sittig SP; Wimmers F; Bakdash G; Schreibelt G; de Vries IJM
    Cancer Immunol Immunother; 2018 Sep; 67(9):1425-1436. PubMed ID: 30019146
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Myeloid Neoplasms with Elevated Plasmacytoid Dendritic Cell Differentiation Reflect the Maturation Process of Dendritic Cells.
    Huang Y; Wang Y; Chang Y; Yuan X; Hao L; Shi H; Lai Y; Huang X; Liu Y
    Cytometry A; 2020 Jan; 97(1):61-69. PubMed ID: 31876105
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dominant expression of the inhibitory FcgammaRIIB prevents antigen presentation by murine plasmacytoid dendritic cells.
    Flores M; Desai DD; Downie M; Liang B; Reilly MP; McKenzie SE; Clynes R
    J Immunol; 2009 Dec; 183(11):7129-39. PubMed ID: 19917701
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dendritic cells as vectors for immunotherapy of tumor and its application for gastric cancer therapy.
    Wu Y; Wang L; Zhang Y
    Cell Mol Immunol; 2004 Oct; 1(5):351-6. PubMed ID: 16285894
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Developmental regulation of MHC II expression and transport in human plasmacytoid-derived dendritic cells.
    Sadaka C; Marloie-Provost MA; Soumelis V; Benaroch P
    Blood; 2009 Mar; 113(10):2127-35. PubMed ID: 19015396
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cross-presentation of cell-associated antigens by dendritic cells.
    Larsson M; Fonteneau JF; Bhardwaj N
    Curr Top Microbiol Immunol; 2003; 276():261-75. PubMed ID: 12797452
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Bidirectional interactions of NK cells and dendritic cells in immunotherapy: current and future perspective.
    Mahmood S; Upreti D; Sow I; Amari A; Nandagopal S; Kung SK
    Immunotherapy; 2015; 7(3):301-8. PubMed ID: 25804481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.